Rani Therapeutics, LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 2010-01-01
- Employees
- -
- Market Cap
- $181.4M
- Website
- http://rcub.ac.in/
An Early Phase Study of RT-114
Phase 1
Not yet recruiting
- Conditions
- Obesity
- Interventions
- Combination Product: RT-114 is the RaniPill capsule with PG-102 for the treatment of obesityOther: Placebo
- First Posted Date
- 2025-03-24
- Last Posted Date
- 2025-03-24
- Lead Sponsor
- RANI Therapeutics
- Target Recruit Count
- 60
- Registration Number
- NCT06891287
Study Evaluating PK of Ustekinumab Administered Orally Via RaniPillâ„¢ Capsule
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2023-06-06
- Last Posted Date
- 2024-01-11
- Lead Sponsor
- RANI Therapeutics
- Target Recruit Count
- 55
- Registration Number
- NCT05890118
- Locations
- 🇦🇺
Nucleus Network, Melbourne, Australia
Study Evaluating PK of PTH Administered Orally Via RaniPillâ„¢ Capsule
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2021-12-20
- Last Posted Date
- 2022-10-31
- Lead Sponsor
- RANI Therapeutics
- Target Recruit Count
- 50
- Registration Number
- NCT05164614
- Locations
- 🇦🇺
Nucleus Network, Melbourne, Australia
Pill Swallow Study
Not Applicable
Completed
- Conditions
- Not Determined
- Interventions
- Other: Mock-RP
- First Posted Date
- 2021-06-03
- Last Posted Date
- 2025-02-12
- Lead Sponsor
- RANI Therapeutics
- Target Recruit Count
- 150
- Registration Number
- NCT04911296
- Locations
- 🇺🇸
Clinical Trials of Texas, San Antonio, Texas, United States
A First-in-Human Study of the RaniPill, an Oral Drug Delivery Platform
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- Combination Product: RaniPill capsule containing octreotide
- First Posted Date
- 2019-01-10
- Last Posted Date
- 2020-10-08
- Lead Sponsor
- RANI Therapeutics
- Target Recruit Count
- 62
- Registration Number
- NCT03798912
- Locations
- 🇦🇺
Nucleus Network, Melbourne, Australia
© Copyright 2025. All Rights Reserved by MedPath